Bendamustine, Obinutuzumab, and Venetoclax in Patients With Untreated Mantle Cell Lymphoma (clinicaltrials.gov) - Oct 3, 2026 - P2 | N=23 | Active, not recruiting | Sponsor: Emory University | Trial completion date: Jul 2026 ➔ Jul 2027
Trial completion date • Hematological Malignancies • Lymphoma • Mantle Cell Lymphoma • Oncology • CCND1
|